Aduro Biotech (ADRO) Sees IPO Price of $17/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Marvell shares jump after giving Google warrants amid custom chip deal
Aduro Biotech (ADRO) IPO Opens Up 88%
April 15, 2015 10:37 AM EDTToday's IPO for Aduro Biotech, Inc. (Nasdaq: ADRO) opened for trading at $32 after pricing 7,000,000 shares of common stock at a price to the public of $17 per share, in-line with the expected pricing.
BofA Merrill Lynch and Leerink Partners LLC are acting as joint book-running... More
